These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26366212)

  • 1. Increased Expression of Eps15 Homology Domain 1 is Associated with Poor Prognosis in Resected Small Cell Lung Cancer.
    Meng Q; Sun W; Li M; Zhao Y; Chen X; Sun L; Cai L
    J Cancer; 2015; 6(10):990-5. PubMed ID: 26366212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Eps15 homology domain 1 is negatively correlated with disease-free survival and overall survival of osteosarcoma patients.
    Yu H; Qu G; Wang Y; Mai W; Bao JJ; Song C; Yao M
    J Orthop Surg Res; 2019 Apr; 14(1):103. PubMed ID: 30975166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TGFβ-1 and EHD1 correlated with survival of non-small cell lung cancer.
    Gao Y; Wang Y; Sun L; Meng Q; Cai L; Dong X
    Tumour Biol; 2014 Sep; 35(9):9371-80. PubMed ID: 24946721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Eps15 homology domain 1 and RAB11FIP3 expression regulate breast cancer progression via promoting epithelial growth factor receptor recycling.
    Tong D; Liang YN; Stepanova AA; Liu Y; Li X; Wang L; Zhang F; Vasilyeva NV
    Tumour Biol; 2017 Feb; 39(2):1010428317691010. PubMed ID: 28215104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased EHD1 in non-small cell lung cancer predicts poor survival.
    Lu H; Meng Q; Wen Y; Hu J; Zhao Y; Cai L
    Thorac Cancer; 2013 Nov; 4(4):422-432. PubMed ID: 28920217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.
    Meng Q; Xing Y; Ren T; Lu H; Xi Y; Jiang Z; Hu J; Li C; Sun L; Sun D; Cai L
    Oncotarget; 2017 Apr; 8(14):22433-22442. PubMed ID: 27531895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J; Meng Q; Zhao Y; Chen X; Cai L
    BMC Cancer; 2016 Jul; 16():470. PubMed ID: 27411790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of filamin-A protein is associated with aggressive phenotype and poor survival outcomes in NSCLC patients treated with platinum-based combination chemotherapy.
    Gachechiladze M; Skarda J; Janikova M; Mgebrishvili G; Kharaishvili G; Kolek V; Grygarkova I; Klein J; Poprachova A; Arabuli M; Kolar Z
    Neoplasma; 2016; 63(2):274-81. PubMed ID: 26774150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
    Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
    Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
    Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.
    Zhang F; Zhang M; Hu G; Cai Q; Xu T
    Tumour Biol; 2015 Nov; 36(11):8287-93. PubMed ID: 26002576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
    Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
    Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of plakoglobin is a potential prognostic biomarker for patients with surgically resected lung adenocarcinoma.
    He X; Zhou T; Yang G; Fang W; Li Z; Zhan J; Zhao Y; Cheng Z; Huang Y; Zhao H; Zhang L
    Oncotarget; 2016 Mar; 7(12):15274-87. PubMed ID: 26933815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.